International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3, Supplement , Pages S28-S35 , 1 March 2010

Radiation Dose–Volume Effects of Optic Nerves and Chiasm

  • Charles Mayo, Ph.D.

      Affiliations

    • Department of Radiation Oncology, University of Massachusetts School of Medicine, Worcester, MA
    • Corresponding Author InformationReprint requests to: Charles Mayo, Ph.D., Department of Radiation Oncology, HB-200, University of Massachusetts Memorial Medical Center, 55 Lake Ave. N, Worcester, MA 01655. Tel: (774) 442-5551; Fax: (774) 422-5006
    • ,
  • Mary K. Martel, Ph.D.

      Affiliations

    • Department of Radiation Oncology, M. D. Anderson Cancer Center, Houston, TX
    • ,
  • Lawrence B. Marks, M.D.

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • John Flickinger, M.D.

      Affiliations

    • Department of Radiation Oncology, University of Pittsburgh Presbyterian Hospital, Pittsburgh, PA
    • ,
  • Jiho Nam, M.D.

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • John Kirkpatrick, M.D., Ph.D.

      Affiliations

    • Department of Radiation Oncology, Duke University Medical Center, Durham, NC

Received 14 November 2008 ,Revised 10 July 2009 ,Accepted 15 July 2009.

References 

  1. Lessell S. Friendly fire: Neurogenic visual loss from radiation therapy. J Neuroophthalmol. 2004;24:243–250
  2. Danesh-Meyer HV. Radiation-induced optic neuropathy. J Clin Neurosci. 2008;15:95–100
  3. Gordon KB, Char DH, Sagerman RH. Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys. 1995;31:1123–1139
  4. Parsons JT, Bova FJ, Fitzgerald CR, et al. Radiation optic neuropathy after megavoltage external-beam irradiation: Analysis of time–dose factors. Int J Radiat Oncol Biol Phys. 1994;30:755–763
  5. Rubin P, Constine LS, Fajardo LF, et al. for the RTOG Late Effects Working Group. Overview: Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys. 1995;31:1041–1042
  6. Pavy JJ, Denekamp J, Letschert J, et al. EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys. 1995;31:1043–1047
  7. van den Bergh AC, Dullaart RP, Hoving MA, et al. Radiation optic neuropathy after external beam radiation therapy for acromegaly. Radiother Oncol. 2003;68:95–100
  8. Hudgins PA, Newman NJ, Dillon WP, et al. Radiation-induced optic neuropathy: Characteristic appearances on gadolinium-enhanced MR. AJNR Am J Neuroradiol. 1992;13:235–238
  9. Kline LB, Kim JY, Ceballos R. Radiation optic neuropathy. Ophthalmology. 1985;92:1118–1126
  10. Celesia GG, DeMarco PJ. Anatomy and physiology of the visual system. J Clin Neurophysiol. 1994;11:482–492
  11. Netter FH, Hansen JT. Atlas of Human Anatomy. 4th ed. Philadelphia: WB Saunders; 2006;
  12. Duus P. Topical Diagnosis in Neurology: Anatomy, Physiology, Signs, Symptoms. 3rd rev. Stuttgart: Thieme; 1998;
  13. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  14. Martel MK, Sandler HM, Cornblath WT, et al. Dose–volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors. Int J Radiat Oncol Biol Phys. 1997;38:273–284
  15. Jiang GL, Tucker SL, Guttenberger R, et al. Radiation-induced injury to the visual pathway. Radiother Oncol. 1994;30:17–25
  16. Hoppe BS, Nelson CJ, Gomez DR, et al. Unresectable carcinoma of the paranasal sinuses: Outcomes and toxicities. Int J Radiat Oncol Biol Phys. 2008;72:763–769
  17. Daly ME, Chen AM, Bucci MK, et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys. 2007;67:151–157
  18. Mackley HB, Reddy CA, Lee SY, et al. Intensity-modulated radiotherapy for pituitary adenomas: The preliminary report of the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys. 2007;67:232–239
  19. Aristizabal S, Caldwell WL, Avila J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Oncol Biol Phys. 1977;2:667–673
  20. Bhandare N, Monroe AT, Morris CG, et al. Does altered fractionation influence the risk of radiation-induced optic neuropathy?. Int J Radiat Oncol Biol Phys. 2005;62:1070–1077
  21. Hoppe BS, Stegman LD, Zelefsky MJ, et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting—The MSKCC experience. Int J Radiat Oncol Biol Phys. 2007;67:691–702
  22. Vatnitsky S, Moyers M, Miller D, et al. Proton dosimetry intercomparison based on the ICRU report 59 protocol. Radiother Oncol. 1999;51:273–279
  23. Newhauser WD, Myers KD, Rosenthal SJ, et al. Proton beam dosimetry for radiosurgery: Implementation of the ICRU Report 59 at the Harvard Cyclotron Laboratory. Phys Med Biol. 2002;47:1369–1389
  24. International Commission on Radiation Units and Measurements. Report 78: Prescribing, recording and reporting proton-beam therapy. J ICRU. 2007;7:49–81
  25. Wenkel E, Thornton AF, Finkelstein D, et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48:1363–1370
  26. Noel G, Habrand JL, Mammar H, et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: The Centre de Protontherapie D'Orsay experience. Int J Radiat Oncol Biol Phys. 2001;51:392–398
  27. Weber DC, Rutz HP, Pedroni ES, et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: The Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys. 2005;63:401–409
  28. Nishimura H, Ogino T, Kawashima M, et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys. 2007;68:758–762
  29. Schulz-Ertner D, Karger CP, Feuerhake A, et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys. 2007;68:449–457
  30. Tishler RB, Loeffler JS, Lunsford LD, et al. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys. 1993;27:215–221
  31. Stafford SL, Pollock BE, Leavitt JA, et al. A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2003;55:1177–1181
  32. Pollock BE, Cochran J, Natt N, et al. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: Results from a 15-year experience. Int J Radiat Oncol Biol Phys. 2008;70:1325–1329
  33. Leber KA, Bergloff J, Pendl G. Dose–response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg. 1998;88:43–50
  34. Flickinger JC, Deutsch M, Lunsford LD. Repeat megavoltage irradiation of pituitary and suprasellar tumors. Int J Radiat Oncol Biol Phys. 1989;17:171–175
  35. Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21:123–135
  36. Brizel DM, Light K, Zhou SM, et al. Conformal radiation therapy treatment planning reduces the dose to the optic structures for patients with tumors of the paranasal sinuses. Radiother Oncol. 1999;51:215–218
  37. Flickinger JC, Kondziolka D, Lunsford LD. Radiobiological analysis of tissue responses following radiosurgery. Technol Cancer Res Treat. 2003;2:87–92
  38. Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol. 2008;18:240–243
  39. Flickinger JC, Lunsford LD, Singer J, et al. Megavoltage external beam irradiation of craniopharyngiomas: Analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys. 1990;19:117–122
  40. Goldsmith BJ, Rosenthal SA, Wara WM, et al. Optic neuropathy after irradiation of meningioma. Radiology. 1992;185:71–76
  41. Shrieve DC, Hazard L, Boucher K, et al. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: Radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg. 2004;101(Suppl. 3):390–395
  42. Finger PT. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol. 2007;143:335–338
  43. Finger PT. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys. 2008;70:974–977
  44. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176–181
  45. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:13–47
  46. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  47. Lee M, Kalani MY, Cheshier S, et al. Radiation therapy and CyberKnife radiosurgery in the management of craniopharyngiomas. Neurosurg Focus. 2008;24:E4
  48. Pigeaud-Klessens ML, Kralendonk JH. Radiation retino- and opticopathy: A prospective study. Doc Ophthalmol. 1992;79:285–291

 Conflict of interest: none.

PII: S0360-3016(09)03284-2

doi: 10.1016/j.ijrobp.2009.07.1753

International Journal of Radiation Oncology * Biology * Physics
Volume 76, Issue 3, Supplement , Pages S28-S35 , 1 March 2010

Article Tools

* Image Usage & Resolution